Keywords: Sanofi-Aventis, Ciltyri, FDA approval, Insomnia

Sanofi-Aventis’ Ciltyri delayed as FDA wants more info

Article | 17 September 2009

Print This

The US Food and Drug Administration has issued a complete response letter regarding the French drug major Sanofi-Aventis's New Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in